Delivery Order SPE2DR25D2206-SPE2DR26F9FP8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8.55K to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,850.83 to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets (30-count units) under a firm fixed price contract. The delivery order, issued on October 27, 2025, with a completion date of November 18, 2025, represents a non-competitive, non-set-aside award to support federal pharmaceutical procurement needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Mekinist 2mg tablets (30-count) with a ceiling value of $30,573.66. This firm fixed-price delivery order represents a non-competitive set-aside contract and is scheduled for completion by January 6, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Mekinist 0.5 mg tablets (30-count units) under a firm fixed-price contract valued at $2,850.83. The award, issued on May 1, 2025, with completion targeted for May 22, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $19.3K delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of May 12, 2025, and performance based in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $10,191.22 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on December 15, 2025. This firm fixed-price delivery order, which is non-competitive and carries an ultimate completion date of January 7, 2026, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Mekinist 2 mg tablets (30-count units) with a contract ceiling value of $10,191.22. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open and competitive procurement. The ultimate completion date is January 5, 2026, and performance will take place at the company's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,053.45 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply Mekinist 0.05 mg/ml solution 90ml. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets. The contract, which is not set aside, has a ceiling value of $2,589.70 and a completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, branded and generic drugs, vaccines, and...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $8,878.79. The order has a completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2025,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FP8Delivery Order
The Defense Logistics Agency awarded a $16,303.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets (30-count units) on December 12, 2025, with completion targeted for January 6, 2026. The award, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This child contract fulfills pharmaceutical supply requirements for federal military and healthcare systems, leveraging the vendor's established position as a critical supplier of brand-name and generic medications to the defense medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a $999,999,999.00 prime IDC with DLA Troop Support Medical running through December 2026, which serves as the parent vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The vendor's contract portfolio demonstrates extensive experience fulfilling federal medical procurement needs across multiple therapeutic domains, with consistent delivery order awards at firm fixed prices, making it a versatile provider capable of meeting diverse federal healthcare supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 12/11/25 |